Business
Ventripoint Receives Additional Funding to Develop Next Generation of the VMS+, Whole-Heart Analysis System
(TheNewswire) Toronto, Ontario - The Newswire - December 6, 2021 - Ventri...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Receives Additional Funding to Develop Next Generation of the VMS+, Whole-Heart Analysis System\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Toronto, Ontario - The Newswire -\nDecember 6, 2021\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n ) (\n \n \n OTC:VPTDF) is pleased to announce\nthat Ventripoint has received additional advisory services and up to\n$107,000 in research and development funding from the National\nResearch Council of Canada Industrial Research Assistance Program (NRC\nIRAP). This new funding is in addition to the up to $120,000 that has\nalready been approved.\n \n \n \n \n “Ventripoint’s mission is to improve cardiac\ndiagnosis for everyone, worldwide and especially for children, so it\nis wonderful to have the support of the Government of Canada through\nNRC IRAP as we push the limits of our technology to even better\nperformance,’ stated Dr. George Adams, CEO of Ventripoint.\n \n \n \n \n It is important for medical device companies to always\nbe advancing their products to keep ahead of the competition and this\nsupport will be used to develop the next generation of the VMS+\nproducts. The Company has been working with an international committee\nof cardiologists to define new measurements of heart function to\nimprove diagnose and patient care.  The combined funding of up to\n$227,000 will provide Ventripoint with the resources and advisory\nservices to further enhance the VMS+ system to revolutionize the way\nheart analysis is performed.\n \n \n \n \n About Ventripoint Diagnostics\nLtd.\n \n \n \n \n Ventripoint\n \n \n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS products are powered by its\nproprietary KBR technology, which is the result of a decade of\ndevelopment and provides accurate volumetric cardiac measurements\nequivalent to MRI. This affordable, gold-standard alternative allows\ncardiologists greater confidence in the management of their patients.\nProviding better care to patients serves as a springboard and basic\nstandard for all of Ventripoint's products that guide our future\ndevelopments. In addition, VMS+ is versatile and can be used with all\nultrasound systems from any vendor supporte...